All articles by GlobalData

Pfizer acquires ADC pioneer Seagen for $43bn

Seagen generated almost $2bn in revenue in 2022, an increase approaching 25% from 2021.

Collaboration with Janssen and Eli Lilly to address lack of paediatric medications

Typically used to evaluate therapies in oncology, the use of master protocols may allow companies to streamline paediatric studies.

GlobalData at ISPOR Europe in Vienna – come see our posters!

GlobalData is pleased to be attending the ISPOR Europe Conference in Vienna, Austria, from 6–9 November 2022.

Global rheumatologists’ biosimilar prescription rates shift from 2018 to 2020

The rate of biosimilar adoption for the treatment of autoimmune diseases varies greatly by geographical market.

Over 50% of all chronic hepatitis B cases go undiagnosed in the 9MM

Chronic hepatitis B (CHB) is a viral liver disease that develops when the immune system cannot fight the hepatitis B virus and it remains in the body for six months or longer.

There is not enough evidence to blame India’s second wave of COVID-19 on mutations

Despite the alarming spike in new cases with India’s second wave, there is simply not enough evidence to place blame on variants.

Bunge Loders Croklaan launches premium lipid ingredient for infant milk formulas

Bunge Loders Croklaan, an oils and fat solutions provider for the global food industry, unveiled a new lipid ingredient called Betapol Select that is claimed to make infant milk formula more suitable for Chinese babies.

Seven million primary and secondary school students may drop out due to Covid-19 pandemic, according to leading macroeconomic influencers

Additional relief measures and stimulus packages needed to prevent stunted economic growth in the US, according to leading macroeconomic influencers

Global economy headed for a V-shaped recovery, according to leading macroeconomic influencers